The determination of the disease phenotype 42 h post-infection showed a clear worsening of clinical symptoms in TAM-treated PDGFRB::creER2-iDTA mice compared to control groups, as evidenced by significantly increased clinical score values, more restricted motor activities, and lower body temperatures (Fig. 3C–E). The gene discussed is PDGFRB; the disease is infection.